BioPharma Dive19h
Enhertu, with new OK, set to supplant chemo in HER2-low breast cancer
The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...
Verywell Health on MSN2h
Navigating Care Through Every Phase of Metastatic Breast Cancer
If you have metastatic breast cancer, you may need help from loved ones and your medical team along the way. Here’s how to ...
Verywell Health on MSN2h
8 Ways to Combat Isolation With a Metastatic Breast Cancer Diagnosis
Several studies show that isolation is very common among those diagnosed with metastatic breast cancer. However, there are ...
Targeted Oncology2h
Elacestrant Shows Greater Benefit in Endocrine-Sensitive Breast Cancer
Paolo Tarantino, MD, PhD, discusses the approval of the oral therapy elacestrant for patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer with ESR1 mutations.
Pharm Exec12h
Spravato’s Transformative Impact: Offering Hope and Rapid Relief for Patients with Depression
Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...
Targeted Oncology11h
Guideline-Directed Treatment Options: mCRPC
Evan Y. Yu, MD, discusses the therapeutic options for metastatic castration-resistant prostate cancer (mCRPC) included in the National Comprehensive Cancer Network (NCCN) guidelines, such as ...
pancan6h
ABOUT Pancreatic Cancer
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.